Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon E Murphy

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 22, 2005
Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6Kari E Dicke, Sara M Skrlin, Sharon E Murphy
Chemical Research in Toxicology|January 18, 2005
Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidineHansen L Wong, Sharon E Murphy, Stephen S Hecht
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2012
CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ionLinda B von Weymarn, Cassandra Retzlaff, Sharon E Murphy
Chemico-Biological Interactions|November 12, 2015
Benzene oxide is a substrate for glutathione S-transferasesAdam T Zarth, Sharon E Murphy, Stephen S Hecht
Chemical Research in Toxicology|December 20, 2005
Identification of N-(hydroxymethyl) norcotinine as a major product of cytochrome P450 2A6, but not cytochrome P450 2A13-catalyzed cotinine metabolismKathryn M Brown, Linda B von Weymarn, Sharon E Murphy
Chemico-Biological Interactions|April 11, 2012
Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and mentholValerie M Kramlinger, Linda B von Weymarn, Sharon E Murphy
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2005
Inactivation of CYP2A6 and CYP2A13 during nicotine metabolismLinda B von Weymarn, Kathryn M Brown, Sharon E Murphy
Carcinogenesis|February 14, 2003
Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3Hansen L Wong, Sharon E Murphy, Mingyao Wang, et al.
Cancer Letters|December 4, 2003
Effects of nicotine infusion on the metabolism of the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in ratsDaniel Keyler, Paul R Pentel, Gwendolyn Kuehl, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometrySharon E Murphy, Peter Villalta, Sing-Wei Ho, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 22, 2005
Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6Kari E Dicke, Sara M Skrlin, Sharon E Murphy
Chemical Research in Toxicology|January 18, 2005
Cytochrome P450 2A-catalyzed metabolic activation of structurally similar carcinogenic nitrosamines: N'-nitrosonornicotine enantiomers, N-nitrosopiperidine, and N-nitrosopyrrolidineHansen L Wong, Sharon E Murphy, Stephen S Hecht
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2012
CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ionLinda B von Weymarn, Cassandra Retzlaff, Sharon E Murphy
Chemico-Biological Interactions|November 12, 2015
Benzene oxide is a substrate for glutathione S-transferasesAdam T Zarth, Sharon E Murphy, Stephen S Hecht
Chemical Research in Toxicology|December 20, 2005
Identification of N-(hydroxymethyl) norcotinine as a major product of cytochrome P450 2A6, but not cytochrome P450 2A13-catalyzed cotinine metabolismKathryn M Brown, Linda B von Weymarn, Sharon E Murphy
Chemico-Biological Interactions|April 11, 2012
Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and mentholValerie M Kramlinger, Linda B von Weymarn, Sharon E Murphy
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2005
Inactivation of CYP2A6 and CYP2A13 during nicotine metabolismLinda B von Weymarn, Kathryn M Brown, Sharon E Murphy
Carcinogenesis|February 14, 2003
Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3Hansen L Wong, Sharon E Murphy, Mingyao Wang, et al.
Cancer Letters|December 4, 2003
Effects of nicotine infusion on the metabolism of the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in ratsDaniel Keyler, Paul R Pentel, Gwendolyn Kuehl, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 24, 2007
Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometrySharon E Murphy, Peter Villalta, Sing-Wei Ho, et al.
Pageof 14